NICHEY

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Memuat..

Jam tangan

Jam tangan Gulungan

Acara

Jelajahi Acara Acara saya

Blog

Jelajahi artikel

Pasar

Produk Terbaru

halaman

Halaman Saya Halaman yang Disukai

Lagi

Forum Mengeksplorasi postingan populer Pekerjaan Penawaran Pendanaan
Gulungan Jam tangan Acara Pasar Blog Halaman Saya Lihat semua

k kumar
k kumar  membuat artikel baru
1 kamu

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics | #healthcare

Lainnya

HR+/HER2- Breast Cancer: The Global Shift in Research and Market Dynamics

HR+ HER2- breast cancer is the most common subtype, making up around 70% of all breast cancer cases. Characterized by hormone receptor positivity and the absence of HER2 overexpression, the prevalence of HR+ HER2- breast cancer varies globally.
Suka
Produk Terbaru Lihat semua